European Case Law Identifier: | ECLI:EP:BA:2018:T108513.20181109 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 09 November 2018 | ||||||||
Case number: | T 1085/13 | ||||||||
Application number: | 06723128.2 | ||||||||
IPC class: | C07D 211/90 A61K 31/435 A61P 9/12 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | B | ||||||||
Download and more information: |
|
||||||||
Title of application: | AMORPHOUS LERCANIDIPINE HYDROCHLORIDE | ||||||||
Applicant name: | Recordati Ireland Limited RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. |
||||||||
Opponent name: | - | ||||||||
Board: | 3.3.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Novelty - (yes) Inventive step - (yes) |
||||||||
Catchwords: |
A claim defining a compound as having a certain purity lacks novelty over a prior-art disclosure describing the same compound only if the prior art discloses the claimed purity at least implicitly, for example by way of a method for preparing said compound, the method inevitably resulting in the purity as claimed. Such a claim, however, does not lack novelty if the disclosure of the prior art needs to be supplemented, for example by suitable (further) purification methods allowing the skilled person to arrive at the claimed purity. The question of whether such (further) purification methods for the prior-art compound are within the common general knowledge of those skilled in the art and, if applied, would result in the claimed purity, is not relevant to novelty, but is rather a matter to be considered in the assessment of inventive step (reasons, 3.7, 3.8). |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t131085eu1.html
Date retrieved: 17 May 2021